Anti-FOXR2 antibody

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FOXR2 also known as Forkhead box protein R2 is a transcription factor with a mass of approximately 31 kDa. It is part of the large family of forkhead transcription factors characterized by a distinct DNA-binding domain known as the "forkhead box". FOXR2 expression is mostly observed in the brain particularly within the central nervous system. Researchers have identified its expression in other tissues under specific conditions indicating a potential role beyond its primary locations.

Biological function summary

FOXR2 influences gene regulation processes involved in cellular growth and differentiation. It does not seem to form large complexes but may interact with other transcription factors or co-regulators to fulfill its functional roles. Its regulatory functions highlight its impact on the development and maintenance of neuronal structures. Evidence suggests that FOXR2 may also participate in controlling cellular metabolism linking it to pathways that manage bioenergetics within the cells.

Pathways

FOXR2 has roles in important developmental pathways and cell cycle regulation. It modulates the Hedgehog signaling pathway a pathway significant in embryonic development and tissue regeneration. FOXR2 works alongside proteins like GLI1 to mediate transcriptional responses. Although not directly involved FOXR2 influences the Wnt signaling pathway which controls cellular proliferation and differentiation aligning its function with proteins such as β-catenin.

FOXR2 has associations with specific cancers particularly brain tumors like gliomas and neuroblastoma. Overexpression or mutations in FOXR2 can disrupt normal cellular growth leading to tumorigenesis. Studies have shown a connection between FOXR2 and MYC a well-known oncogene in the context of tumor progression. Additionally schizophrenia has correlations with aberrant FOXR2 expression linking it indirectly to proteins involved in neurodevelopment such as DISC1. Understanding these associations opens potential for developing therapies targeting FOXR2-related pathways.